StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a research report report published on Friday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock.
Evoke Pharma Trading Down 1.8 %
Shares of Evoke Pharma stock opened at $0.65 on Friday. The company has a fifty day simple moving average of $0.78 and a 200-day simple moving average of $1.06. Evoke Pharma has a 12-month low of $0.56 and a 12-month high of $3.70. The company has a current ratio of 3.50, a quick ratio of 3.27 and a debt-to-equity ratio of 9.29. The stock has a market cap of $2.17 million, a price-to-earnings ratio of -0.29 and a beta of 0.21.
About Evoke Pharma
Featured Articles
- Five stocks we like better than Evoke Pharma
- Retail Stocks Investing, Explained
- MarketBeat Week in Review – 2/26 – 3/1
- Insider Selling Explained: Can it Inform Your Investing Choices?
- How to Buy Bitcoin Stock: 3 Easy Ways to Do It
- Manufacturing Stocks Investing
- Snowflake Stock Plunges, Don’t be Fooled, Bargain Alert
Receive News & Ratings for Evoke Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke Pharma and related companies with MarketBeat.com's FREE daily email newsletter.